EUVIMEDEUVIMED entdecken
Crossref

Discovery of Potent and Selective THRβ Agonists Based on an N -Benzoylglycine Scaffold for the Treatment of Metabolic Disorders

Yue Wu iD, Linjian Zhang, Xiao Li, Ruiheng Cao, Shuang Han, Shanrui Li, Wei Shen Aik iD, Haoshu Zhang, Peiyao Yang, Tiande Bing, Le Yang, Fulai Yang und 2 weitere

Journal of Medicinal Chemistry · 13.08.2026 · 69 (15) · 19279-19298

DOI: 10.1021/acs.jmedchem.6c01599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 16.07.2026. Verfasst von Yue Wu und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Design and Optimization, Department of Chemistry, China Pharmaceutical Univ…. Hauptthemen laut MEDLINE: Glycine, Metabolic Diseases, Thyroid Hormone Receptors beta, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Basic Research Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic disorders, including obesity, dyslipidemia, and metabolic dysfunction-associated steatohepatitis (MASH), pose a growing health burden with limited pharmacological options. Thyroid hormone receptor β (THRβ) is a liver-enriched nuclear receptor that regulates lipid metabolism, mitochondrial function, and energy homeostasis, making it a promising therapeutic target. Guided by structural insights, we designed an N-benzoylglycine scaffold as a new chemotype, which provides selectivity for the THRβ receptor against THRα while preserving key interactions with the arginine-rich positively charged pocket. Conformational restriction was introduced to maintain a near-orthogonal orientation that optimizes ligand insertion and hydrogen-bonding with His435. Among the series, compound 18 (ZG-2585) exhibited potent and selective THRβ activation and favorable pharmacokinetic profiles. In a western-diet-induced metabolic disorder mouse model, oral administration of ZG-2585 improved body weight, hepatic steatosis, and lipid accumulation. These results establish the N-benzoylglycine scaffold as a promising chemotype for developing selective, orally active THRβ agonists for metabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycineMetabolic DiseasesThyroid Hormone Receptors betaDrug DiscoveryAnimalsMiceHumansStructure-Activity RelationshipMaleMice, Inbred C57BL

Substanzen

GlycineThyroid Hormone Receptors beta

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Design and Optimization, Department of Chemistry, China Pharmaceutical University, Nanjing211198, China.
  • Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing211198, China.
  • Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR999077, China.

ORCID-Profile: Yue Wu, Wei Shen Aik, Xiang Li, Xiaojin Zhang

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Basic Research Program of Jiangsu Province
  • Fundamental Research Funds for the Central Universities
  • Innovative Drug Research and Development National Science and Technology Major Project

Zitieren

APA

Wu, Y., Zhang, L., Li, X., Cao, R., Han, S., Li, S., Aik, W. S., Zhang, H., Yang, P., Bing, T., Yang, L., Yang, F., Li, X., & Zhang, X. (2026). Discovery of Potent and Selective THRβ Agonists Based on an N -Benzoylglycine Scaffold for the Treatment of Metabolic Disorders. Journal of Medicinal Chemistry, 69(15), 19279-19298. https://doi.org/10.1021/acs.jmedchem.6c01599

Vancouver

Wu Y, Zhang L, Li X, Cao R, Han S, Li S, et al. Discovery of Potent and Selective THRβ Agonists Based on an N -Benzoylglycine Scaffold for the Treatment of Metabolic Disorders. Journal of Medicinal Chemistry. 2026;69(15):19279-19298. doi:10.1021/acs.jmedchem.6c01599

BibTeX
@article{Wu2026,
  author = {Wu, Yue and Zhang, Linjian and Li, Xiao and Cao, Ruiheng and Han, Shuang and Li, Shanrui and Aik, Wei Shen and Zhang, Haoshu and Yang, Peiyao and Bing, Tiande and Yang, Le and Yang, Fulai and Li, Xiang and Zhang, Xiaojin},
  title = {Discovery of Potent and Selective THRβ Agonists Based on an N -Benzoylglycine Scaffold for the Treatment of Metabolic Disorders},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {15},
  pages = {19279--19298},
  doi = {10.1021/acs.jmedchem.6c01599}
}
Kostenlos starten →